Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Renewables & cleantech

American Eagle Gold stock climbs on copper equivalent results plus more daily small cap movers

A long copper equivalent interval boosted shares of American Eagle Gold Corp Wednesday plus other big percentage movers on news from the small and micro cap space

4:05pm: Gratomic, District Metals holds onto gains late day

American Eagle Gold closed up 3% at $0.20. while Gratomic rose 11% to $0.30, Small Pharma finished 10% higher to $0.11, and District Metals ended up 13% at $0.17.

11:30am: American Eagle Gold, Small Pharma shares make big gains

American Eagle Gold Corp (TSX-V:AE) shares jumped 18% to $0.23 on Wednesday after the junior explorer announced what it called promising assay results from the third and fourth holes of the 2022 program on its NAK copper-gold porphyry project in British Columbia, which included 527 metres of 0.45% copper equivalent from surface.

READ: American Eagle Gold reports promising assay results from 2022 program at NAK copper-gold porphyry project

As well, shares of Gratomic Inc (TSXV:GRAT) gained 11% to $0.30 as the company focused on becoming a leading global graphite supplier said it has signed a non-binding Letter of Intent (LOI) with Graphex Group Limited and its US subsidiary, Graphex Technologies LLC, with an aim of combining Gratomic's raw material supply capabilities with Graphex's downstream processing expertise to solve an industry-wide supply-demand gap by delivering “an end-to-end supply of graphite from mine to battery” with facilities to be located in North America.

Small Pharma Inc (TSX-V:DMT, OTCQB:DMTTF), meanwhile, reported that SPL026, intravenous N,N-Dimethyltryptamine (DMT), with supportive therapy for the treatment of Major Depressive Disorder (MDD) met the primary endpoint in its Phase IIa clinical trial, demonstrating a statistically significant and clinically relevant reduction in depressive symptoms at two-weeks post-dose, as compared to the placebo. Small Pharma stock moved up 25% to $0.125 following the announcement.

And, District Metals Corp (TSXV:DMX) shares rose 13% to $0.17 on Wednesday after the prospective mineral properties developer hailed Swedish media reports that a majority within the Swedish parliament is likely to support the exploration and mining of uranium in the country, ending a moratorium in place since 2018.

Contact Sean at sean@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK